<DOC>
	<DOCNO>NCT01441336</DOCNO>
	<brief_summary>Although laparoscopic gastrectomy ( LG ) widely use treatment early gastric cancer , report efficacy LAG management advance gastric cancer ( AGC ) . The aim study evaluate surgical outcome oncologic safety laparoscopic gastrectomy AGC .</brief_summary>
	<brief_title>Laparoscopic Gastrectomy Advanced Gastric Cancer</brief_title>
	<detailed_description>Prospective phase II clinical trial evaluate technical oncological safety LG AGC LG procedure AGC : D2 lymphadenectomy Total omentectomy tumor serosa exposure laparoscopic exploration Primary end point : 3 year disease free survival secondary end point : postoperative outcome , morbidity mortality , 3,5 7 year overall survival , Quality life , recurrence pattern Study duration : 7 year ( enrollment : 4year , follow-up : 3year )</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Age 2080 inform consent malignancy cT2N0cT3N2 accord JGCA 2nd edition ASA score &lt; 3 distant metastasis ( P1 M1 ) laparoscopic exploration Conglomerated N2 early gastric cancer permanent pathologic report</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>